文献速递免疫规划慢病防控与筛查

希腊自身免疫性风湿病患者肺炎球菌疫苗接种临床审计:认知的力量

A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness.
PubMed 文献 · Vaccine · 2021-02-18

该研究在希腊一家门诊对395例自身免疫性风湿病患者进行问卷调查,评估肺炎球菌疫苗接种率及影响因素。结果显示接种率为49.37%,仅8.21%按国家指南完成第二剂;年龄>65岁和完全知晓接种理由显著影响接种决策,未接种主要原因是医生未建议。

要点

  • 自身免疫性风湿病患者肺炎球菌疫苗接种率仅49.37%,远未达标。
  • 仅8.21%患者按国家指南接种了第二剂肺炎球菌疫苗。
  • 医生未建议是未接种的主要原因(82.50%)。

核心结论

  • 自身免疫性风湿病患者肺炎球菌疫苗接种率不理想,需提高患者认知和医生建议。

主要发现

  • 肺炎球菌疫苗接种率为49.37%,45.06%在近五年内接种,仅8.21%接种了第二剂。
  • 年龄>65岁(p < 0.001)和完全知晓接种理由(p < 0.001)显著影响接种决策。
  • 合并症、风湿病类型或生物制剂使用不影响接种。
  • 未接种主要原因是医生未建议(82.50%)。

关键数值与推荐

  • 接种率49.37%;近五年接种45.06%;第二剂接种8.21%。
  • 年龄>65岁和完全知晓理由与接种显著相关(p < 0.001)。

临床怎么用

  • 风湿病门诊应主动向患者建议肺炎球菌疫苗接种,并加强接种理由教育。

局限性

  • 单中心门诊调查,样本来自单一科室,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with autoimmune rheumatic diseases (ARDs) are at increased risk for pneumococcal infections and should be vaccinated against Streptococcus pneumoniae. Data on the rates of pneumococcal vaccination among patients with ARDs in Southern Europe are scarce. Here, we estimate the pneumococcal vaccination rate in patients living in Greece with ARDs, explore the patients' awareness regarding vaccination, and try to recognize factors that influence the vaccine uptake. METHODS: Between October 2015 and September 2016, a structured questionnaire was provided to all consecutive patients with ARDs attending one outpatient clinic of our department. The survey included parameters concerning patients' demographics, underlying ARD and immunosuppressive medications, other comorbidities, vaccine type, knowledge about infection risk and necessity of vaccination. Univariate and multivariate analyses were performed to study any association of these factors with the vaccination uptake. RESULTS: Overall, 395 patients with ARDs (30.13% aged >65 years and 78.99% female) participated in our survey. The most frequent ARD was rheumatoid arthritis (43.04%); 40.51% of patients were receiving biologic agents and 44.56% steroids. Pneumococcal vaccination rate was 49.37%, while 45.06% of patients have been vaccinated during the last five years and only 8.21% of them had a second pneumococcal vaccine, as per national guidelines. The decision of vaccination was significantly influenced by the patient's age (>65 years) (p < 0.001) and the complete awareness of reasons for being vaccinated (p < 0.001), but not by presence of comorbidities, the type of ARD or administration of a biologic agent. The main reason for no vaccination was that it was not suggested by the caring physician (82.50%). CONCLUSIONS: In our cohort of patients with ARDs the pneumococcal vaccination was suboptimal. Better understanding of the significance of vaccination by the patient and suggestion for vaccination by the caring physician will improve vaccination uptake and optimize the clinical benefits among patients with ARDs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Constantinou CA, Ziogas DC, Venetsanopoulou A, et al. A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness. Vaccine. 2021. PMID: 33610375. doi:10.1016/j.vaccine.2021.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。